Yale Cancer Center Grand Rounds: Immune Checkpoint Inhibition and Novel Therapies for Myelodysplastic Syndromes/Neoplasms

Associate Professor of Internal Medicine (Hematology); Director, Early Therapeutics Research, Hematology; Leader, Clinical Research Team for Leukemias and Myeloid Malignancies, Yale Cancer Center; Chair, Protocol Review Committee (PRC) I, Yale Cancer Center; Assistant Medical Director, Clinical Trials Office (CTO), Yale Cancer Center; Director, Hematology Research Seminar Series, Hematology; Member, Executive Committee, Yale Cancer Center; Member, Clinical Trials Advisory Committee (CTAC), Yale Cancer Center; Interim Chief, Hematologic Malignancies